nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—QPRT—female reproductive system—ovarian cancer	0.0172	0.0627	CbGeAlD
Niacin—NNMT—myometrium—ovarian cancer	0.0139	0.0507	CbGeAlD
Niacin—HCAR2—testis—ovarian cancer	0.0116	0.0424	CbGeAlD
Niacin—NNMT—uterine cervix—ovarian cancer	0.0108	0.0394	CbGeAlD
Niacin—NNMT—decidua—ovarian cancer	0.0103	0.0376	CbGeAlD
Niacin—NNMT—endometrium—ovarian cancer	0.00978	0.0357	CbGeAlD
Niacin—SLC16A3—myometrium—ovarian cancer	0.00949	0.0346	CbGeAlD
Niacin—NNMT—uterus—ovarian cancer	0.00901	0.0329	CbGeAlD
Niacin—HCAR2—lymph node—ovarian cancer	0.00842	0.0307	CbGeAlD
Niacin—NNMT—female reproductive system—ovarian cancer	0.0081	0.0295	CbGeAlD
Niacin—NNMT—bone marrow—ovarian cancer	0.00765	0.0279	CbGeAlD
Niacin—SLC16A3—epithelium—ovarian cancer	0.00745	0.0272	CbGeAlD
Niacin—SLC16A3—uterine cervix—ovarian cancer	0.00739	0.0269	CbGeAlD
Niacin—NNMT—female gonad—ovarian cancer	0.00737	0.0269	CbGeAlD
Niacin—NNMT—vagina—ovarian cancer	0.00733	0.0267	CbGeAlD
Niacin—SLC16A3—decidua—ovarian cancer	0.00704	0.0257	CbGeAlD
Niacin—SLC16A3—endometrium—ovarian cancer	0.00668	0.0244	CbGeAlD
Niacin—NNMT—testis—ovarian cancer	0.00654	0.0238	CbGeAlD
Niacin—SLC16A3—gonad—ovarian cancer	0.0062	0.0226	CbGeAlD
Niacin—SLC16A3—uterus—ovarian cancer	0.00616	0.0225	CbGeAlD
Niacin—SLC16A3—female reproductive system—ovarian cancer	0.00553	0.0202	CbGeAlD
Niacin—SLC16A3—bone marrow—ovarian cancer	0.00522	0.0191	CbGeAlD
Niacin—SLC16A3—female gonad—ovarian cancer	0.00503	0.0184	CbGeAlD
Niacin—NNMT—lymph node—ovarian cancer	0.00474	0.0173	CbGeAlD
Niacin—SLC16A1—epithelium—ovarian cancer	0.00452	0.0165	CbGeAlD
Niacin—SLC16A3—testis—ovarian cancer	0.00447	0.0163	CbGeAlD
Niacin—SLC16A1—decidua—ovarian cancer	0.00427	0.0156	CbGeAlD
Niacin—SLC16A1—endometrium—ovarian cancer	0.00406	0.0148	CbGeAlD
Niacin—SLC16A1—gonad—ovarian cancer	0.00376	0.0137	CbGeAlD
Niacin—SLC16A1—uterus—ovarian cancer	0.00374	0.0136	CbGeAlD
Niacin—SLCO2B1—decidua—ovarian cancer	0.00368	0.0134	CbGeAlD
Niacin—SLC16A1—female reproductive system—ovarian cancer	0.00336	0.0123	CbGeAlD
Niacin—SLC22A5—myometrium—ovarian cancer	0.00329	0.012	CbGeAlD
Niacin—SLC16A3—lymph node—ovarian cancer	0.00324	0.0118	CbGeAlD
Niacin—SLCO2B1—uterus—ovarian cancer	0.00322	0.0117	CbGeAlD
Niacin—SLC16A1—female gonad—ovarian cancer	0.00306	0.0112	CbGeAlD
Niacin—SLCO2B1—female reproductive system—ovarian cancer	0.00289	0.0105	CbGeAlD
Niacin—SLC16A1—testis—ovarian cancer	0.00271	0.00989	CbGeAlD
Niacin—SLCO2B1—female gonad—ovarian cancer	0.00263	0.0096	CbGeAlD
Niacin—SLC22A5—uterine cervix—ovarian cancer	0.00256	0.00935	CbGeAlD
Niacin—SLCO2B1—testis—ovarian cancer	0.00233	0.00851	CbGeAlD
Niacin—SLC22A5—endometrium—ovarian cancer	0.00232	0.00846	CbGeAlD
Niacin—SLC16A1—lymph node—ovarian cancer	0.00197	0.00717	CbGeAlD
Niacin—SLC22A5—female reproductive system—ovarian cancer	0.00192	0.007	CbGeAlD
Niacin—SLC22A5—female gonad—ovarian cancer	0.00175	0.00637	CbGeAlD
Niacin—SLC22A5—vagina—ovarian cancer	0.00174	0.00634	CbGeAlD
Niacin—SLCO2B1—lymph node—ovarian cancer	0.00169	0.00617	CbGeAlD
Niacin—SLC22A5—testis—ovarian cancer	0.00155	0.00565	CbGeAlD
Niacin—CYP2D6—female reproductive system—ovarian cancer	0.00124	0.00452	CbGeAlD
Niacin—CYP2D6—female gonad—ovarian cancer	0.00113	0.00411	CbGeAlD
Niacin—SLC22A5—lymph node—ovarian cancer	0.00112	0.0041	CbGeAlD
Niacin—CYP2D6—testis—ovarian cancer	0.001	0.00365	CbGeAlD
Niacin—Dermatitis—Topotecan—ovarian cancer	0.000546	0.000992	CcSEcCtD
Niacin—Headache—Topotecan—ovarian cancer	0.000543	0.000987	CcSEcCtD
Niacin—Palpitations—Paclitaxel—ovarian cancer	0.00054	0.000981	CcSEcCtD
Niacin—Angiopathy—Docetaxel—ovarian cancer	0.000539	0.000981	CcSEcCtD
Niacin—Vomiting—Melphalan—ovarian cancer	0.000539	0.00098	CcSEcCtD
Niacin—Loss of consciousness—Paclitaxel—ovarian cancer	0.000537	0.000976	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000536	0.000975	CcSEcCtD
Niacin—Liver function test abnormal—Epirubicin—ovarian cancer	0.000535	0.000973	CcSEcCtD
Niacin—Rash—Melphalan—ovarian cancer	0.000535	0.000972	CcSEcCtD
Niacin—Dermatitis—Melphalan—ovarian cancer	0.000534	0.000971	CcSEcCtD
Niacin—Chills—Docetaxel—ovarian cancer	0.000533	0.00097	CcSEcCtD
Niacin—Cough—Paclitaxel—ovarian cancer	0.000533	0.000969	CcSEcCtD
Niacin—Asthenia—Vinorelbine—ovarian cancer	0.000532	0.000966	CcSEcCtD
Niacin—Dry skin—Epirubicin—ovarian cancer	0.000531	0.000966	CcSEcCtD
Niacin—Arrhythmia—Docetaxel—ovarian cancer	0.000531	0.000966	CcSEcCtD
Niacin—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000529	0.000963	CcSEcCtD
Niacin—Migraine—Doxorubicin—ovarian cancer	0.000528	0.00096	CcSEcCtD
Niacin—Alopecia—Docetaxel—ovarian cancer	0.000525	0.000955	CcSEcCtD
Niacin—Pruritus—Vinorelbine—ovarian cancer	0.000524	0.000953	CcSEcCtD
Niacin—Arthralgia—Paclitaxel—ovarian cancer	0.00052	0.000945	CcSEcCtD
Niacin—Myalgia—Paclitaxel—ovarian cancer	0.00052	0.000945	CcSEcCtD
Niacin—Face oedema—Doxorubicin—ovarian cancer	0.000518	0.000941	CcSEcCtD
Niacin—Malnutrition—Docetaxel—ovarian cancer	0.000517	0.000941	CcSEcCtD
Niacin—Erythema—Docetaxel—ovarian cancer	0.000517	0.000941	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000516	0.000939	CcSEcCtD
Niacin—Nausea—Topotecan—ovarian cancer	0.000514	0.000935	CcSEcCtD
Niacin—Muscular weakness—Epirubicin—ovarian cancer	0.000511	0.00093	CcSEcCtD
Niacin—Dry mouth—Paclitaxel—ovarian cancer	0.000508	0.000924	CcSEcCtD
Niacin—Diarrhoea—Vinorelbine—ovarian cancer	0.000507	0.000922	CcSEcCtD
Niacin—Abdominal distension—Epirubicin—ovarian cancer	0.000504	0.000917	CcSEcCtD
Niacin—Nausea—Melphalan—ovarian cancer	0.000504	0.000916	CcSEcCtD
Niacin—Influenza—Epirubicin—ovarian cancer	0.000501	0.000911	CcSEcCtD
Niacin—Dysphagia—Epirubicin—ovarian cancer	0.000501	0.000911	CcSEcCtD
Niacin—Oedema—Paclitaxel—ovarian cancer	0.000498	0.000906	CcSEcCtD
Niacin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000498	0.000906	CcSEcCtD
Niacin—Muscle spasms—Docetaxel—ovarian cancer	0.000498	0.000905	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000495	0.0009	CcSEcCtD
Niacin—Dry skin—Doxorubicin—ovarian cancer	0.000492	0.000894	CcSEcCtD
Niacin—Shock—Paclitaxel—ovarian cancer	0.00049	0.000891	CcSEcCtD
Niacin—Dizziness—Vinorelbine—ovarian cancer	0.00049	0.000891	CcSEcCtD
Niacin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00049	0.000891	CcSEcCtD
Niacin—Angina pectoris—Epirubicin—ovarian cancer	0.000488	0.000887	CcSEcCtD
Niacin—Tachycardia—Paclitaxel—ovarian cancer	0.000486	0.000884	CcSEcCtD
Niacin—Skin disorder—Paclitaxel—ovarian cancer	0.000484	0.00088	CcSEcCtD
Niacin—Bronchitis—Epirubicin—ovarian cancer	0.000482	0.000876	CcSEcCtD
Niacin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000482	0.000876	CcSEcCtD
Niacin—Anorexia—Paclitaxel—ovarian cancer	0.000475	0.000864	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—ovarian cancer	0.000473	0.00086	CcSEcCtD
Niacin—Vomiting—Vinorelbine—ovarian cancer	0.000471	0.000856	CcSEcCtD
Niacin—Rash—Vinorelbine—ovarian cancer	0.000467	0.000849	CcSEcCtD
Niacin—Dermatitis—Vinorelbine—ovarian cancer	0.000467	0.000849	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—ovarian cancer	0.000467	0.000849	CcSEcCtD
Niacin—Hypotension—Paclitaxel—ovarian cancer	0.000466	0.000847	CcSEcCtD
Niacin—Headache—Vinorelbine—ovarian cancer	0.000464	0.000844	CcSEcCtD
Niacin—Syncope—Docetaxel—ovarian cancer	0.000464	0.000844	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—ovarian cancer	0.000464	0.000843	CcSEcCtD
Niacin—Influenza—Doxorubicin—ovarian cancer	0.000464	0.000843	CcSEcCtD
Niacin—Leukopenia—Docetaxel—ovarian cancer	0.000463	0.000842	CcSEcCtD
Niacin—Palpitations—Docetaxel—ovarian cancer	0.000457	0.000832	CcSEcCtD
Niacin—Loss of consciousness—Docetaxel—ovarian cancer	0.000455	0.000827	CcSEcCtD
Niacin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000454	0.000825	CcSEcCtD
Niacin—Cough—Docetaxel—ovarian cancer	0.000452	0.000821	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—ovarian cancer	0.000452	0.000821	CcSEcCtD
Niacin—Insomnia—Paclitaxel—ovarian cancer	0.000451	0.00082	CcSEcCtD
Niacin—Paraesthesia—Paclitaxel—ovarian cancer	0.000447	0.000814	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—ovarian cancer	0.000446	0.000811	CcSEcCtD
Niacin—Dyspnoea—Paclitaxel—ovarian cancer	0.000444	0.000808	CcSEcCtD
Niacin—Somnolence—Paclitaxel—ovarian cancer	0.000443	0.000805	CcSEcCtD
Niacin—Myalgia—Docetaxel—ovarian cancer	0.000441	0.000801	CcSEcCtD
Niacin—Arthralgia—Docetaxel—ovarian cancer	0.000441	0.000801	CcSEcCtD
Niacin—Nausea—Vinorelbine—ovarian cancer	0.00044	0.0008	CcSEcCtD
Niacin—Dyspepsia—Paclitaxel—ovarian cancer	0.000439	0.000798	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000438	0.000796	CcSEcCtD
Niacin—Jaundice—Epirubicin—ovarian cancer	0.000435	0.000792	CcSEcCtD
Niacin—Stomatitis—Epirubicin—ovarian cancer	0.000435	0.000792	CcSEcCtD
Niacin—Decreased appetite—Paclitaxel—ovarian cancer	0.000433	0.000788	CcSEcCtD
Niacin—Dry mouth—Docetaxel—ovarian cancer	0.000431	0.000784	CcSEcCtD
Niacin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00043	0.000782	CcSEcCtD
Niacin—Sweating—Epirubicin—ovarian cancer	0.000428	0.000779	CcSEcCtD
Niacin—Pain—Paclitaxel—ovarian cancer	0.000426	0.000775	CcSEcCtD
Niacin—Oedema—Docetaxel—ovarian cancer	0.000422	0.000768	CcSEcCtD
Niacin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000422	0.000768	CcSEcCtD
Niacin—Shock—Docetaxel—ovarian cancer	0.000416	0.000756	CcSEcCtD
Niacin—Tachycardia—Docetaxel—ovarian cancer	0.000412	0.00075	CcSEcCtD
Niacin—Skin disorder—Docetaxel—ovarian cancer	0.00041	0.000746	CcSEcCtD
Niacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000407	0.000741	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—ovarian cancer	0.000403	0.000733	CcSEcCtD
Niacin—Jaundice—Doxorubicin—ovarian cancer	0.000403	0.000733	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—ovarian cancer	0.000403	0.000733	CcSEcCtD
Niacin—Anorexia—Docetaxel—ovarian cancer	0.000403	0.000732	CcSEcCtD
Niacin—Rhinitis—Epirubicin—ovarian cancer	0.000402	0.000731	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—ovarian cancer	0.000401	0.000729	CcSEcCtD
Niacin—Hepatitis—Epirubicin—ovarian cancer	0.000401	0.000729	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000399	0.000725	CcSEcCtD
Niacin—Sweating—Doxorubicin—ovarian cancer	0.000396	0.00072	CcSEcCtD
Niacin—Urticaria—Paclitaxel—ovarian cancer	0.000396	0.00072	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—ovarian cancer	0.000395	0.000718	CcSEcCtD
Niacin—Hypotension—Docetaxel—ovarian cancer	0.000395	0.000718	CcSEcCtD
Niacin—Abdominal pain—Paclitaxel—ovarian cancer	0.000394	0.000716	CcSEcCtD
Niacin—Body temperature increased—Paclitaxel—ovarian cancer	0.000394	0.000716	CcSEcCtD
Niacin—Visual impairment—Epirubicin—ovarian cancer	0.000386	0.000703	CcSEcCtD
Niacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000385	0.0007	CcSEcCtD
Niacin—Insomnia—Docetaxel—ovarian cancer	0.000382	0.000695	CcSEcCtD
Niacin—Paraesthesia—Docetaxel—ovarian cancer	0.000379	0.00069	CcSEcCtD
Niacin—Dyspnoea—Docetaxel—ovarian cancer	0.000377	0.000685	CcSEcCtD
Niacin—Somnolence—Docetaxel—ovarian cancer	0.000375	0.000683	CcSEcCtD
Niacin—Eye disorder—Epirubicin—ovarian cancer	0.000375	0.000681	CcSEcCtD
Niacin—Tinnitus—Epirubicin—ovarian cancer	0.000374	0.00068	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—ovarian cancer	0.000373	0.000678	CcSEcCtD
Niacin—Flushing—Epirubicin—ovarian cancer	0.000372	0.000677	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—ovarian cancer	0.000372	0.000676	CcSEcCtD
Niacin—Dyspepsia—Docetaxel—ovarian cancer	0.000372	0.000676	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—ovarian cancer	0.000371	0.000675	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—ovarian cancer	0.000371	0.000675	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000369	0.000671	CcSEcCtD
Niacin—Decreased appetite—Docetaxel—ovarian cancer	0.000367	0.000668	CcSEcCtD
Niacin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000367	0.000668	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000365	0.000665	CcSEcCtD
Niacin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000365	0.000663	CcSEcCtD
Niacin—Angiopathy—Epirubicin—ovarian cancer	0.000364	0.000662	CcSEcCtD
Niacin—Pain—Docetaxel—ovarian cancer	0.000361	0.000657	CcSEcCtD
Niacin—Chills—Epirubicin—ovarian cancer	0.00036	0.000654	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—ovarian cancer	0.000358	0.000651	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—ovarian cancer	0.000358	0.00065	CcSEcCtD
Niacin—Asthenia—Paclitaxel—ovarian cancer	0.000358	0.00065	CcSEcCtD
Niacin—Alopecia—Epirubicin—ovarian cancer	0.000354	0.000644	CcSEcCtD
Niacin—Pruritus—Paclitaxel—ovarian cancer	0.000353	0.000641	CcSEcCtD
Niacin—Malnutrition—Epirubicin—ovarian cancer	0.000349	0.000635	CcSEcCtD
Niacin—Erythema—Epirubicin—ovarian cancer	0.000349	0.000635	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—ovarian cancer	0.000347	0.00063	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—ovarian cancer	0.000346	0.000629	CcSEcCtD
Niacin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000345	0.000628	CcSEcCtD
Niacin—Flushing—Doxorubicin—ovarian cancer	0.000344	0.000626	CcSEcCtD
Niacin—Flatulence—Epirubicin—ovarian cancer	0.000344	0.000625	CcSEcCtD
Niacin—Tension—Epirubicin—ovarian cancer	0.000343	0.000623	CcSEcCtD
Niacin—Diarrhoea—Paclitaxel—ovarian cancer	0.000341	0.00062	CcSEcCtD
Niacin—Nervousness—Epirubicin—ovarian cancer	0.000339	0.000616	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—ovarian cancer	0.000337	0.000612	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—ovarian cancer	0.000336	0.00061	CcSEcCtD
Niacin—Abdominal pain—Docetaxel—ovarian cancer	0.000334	0.000607	CcSEcCtD
Niacin—Body temperature increased—Docetaxel—ovarian cancer	0.000334	0.000607	CcSEcCtD
Niacin—Chills—Doxorubicin—ovarian cancer	0.000333	0.000605	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—ovarian cancer	0.000331	0.000603	CcSEcCtD
Niacin—Dizziness—Paclitaxel—ovarian cancer	0.000329	0.000599	CcSEcCtD
Niacin—Vision blurred—Epirubicin—ovarian cancer	0.000329	0.000598	CcSEcCtD
Niacin—Alopecia—Doxorubicin—ovarian cancer	0.000328	0.000596	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PGR—ovarian cancer	0.000324	0.00184	CbGpPWpGaD
Niacin—Erythema—Doxorubicin—ovarian cancer	0.000323	0.000587	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—ovarian cancer	0.000323	0.000587	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000322	0.00183	CbGpPWpGaD
Niacin—QPRT—Metabolism—TYMS—ovarian cancer	0.000322	0.00183	CbGpPWpGaD
Niacin—Flatulence—Doxorubicin—ovarian cancer	0.000318	0.000579	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PARP1—ovarian cancer	0.000318	0.00181	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000318	0.00181	CbGpPWpGaD
Niacin—Tension—Doxorubicin—ovarian cancer	0.000317	0.000576	CcSEcCtD
Niacin—Vomiting—Paclitaxel—ovarian cancer	0.000317	0.000576	CcSEcCtD
Niacin—Rash—Paclitaxel—ovarian cancer	0.000314	0.000571	CcSEcCtD
Niacin—Dermatitis—Paclitaxel—ovarian cancer	0.000314	0.000571	CcSEcCtD
Niacin—Nervousness—Doxorubicin—ovarian cancer	0.000314	0.00057	CcSEcCtD
Niacin—Vertigo—Epirubicin—ovarian cancer	0.000314	0.00057	CcSEcCtD
Niacin—Syncope—Epirubicin—ovarian cancer	0.000313	0.000569	CcSEcCtD
Niacin—Leukopenia—Epirubicin—ovarian cancer	0.000312	0.000568	CcSEcCtD
Niacin—Headache—Paclitaxel—ovarian cancer	0.000312	0.000568	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—ovarian cancer	0.000311	0.00177	CbGpPWpGaD
Niacin—Hypersensitivity—Docetaxel—ovarian cancer	0.000311	0.000566	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—ovarian cancer	0.000311	0.000565	CcSEcCtD
Niacin—QPRT—Disease—CAV1—ovarian cancer	0.00031	0.00176	CbGpPWpGaD
Niacin—Palpitations—Epirubicin—ovarian cancer	0.000308	0.000561	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—ovarian cancer	0.000307	0.000558	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000305	0.00173	CbGpPWpGaD
Niacin—NNMT—Metabolism—ABCB1—ovarian cancer	0.000305	0.00173	CbGpPWpGaD
Niacin—Cough—Epirubicin—ovarian cancer	0.000305	0.000554	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—ovarian cancer	0.000304	0.000553	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—IL6ST—ovarian cancer	0.000304	0.00173	CbGpPWpGaD
Niacin—Asthenia—Docetaxel—ovarian cancer	0.000303	0.000551	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PARP1—ovarian cancer	0.000302	0.00171	CbGpPWpGaD
Niacin—NNMT—Metabolism—TYMS—ovarian cancer	0.000299	0.0017	CbGpPWpGaD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000299	0.0017	CbGpPWpGaD
Niacin—Pruritus—Docetaxel—ovarian cancer	0.000299	0.000543	CcSEcCtD
Niacin—Myalgia—Epirubicin—ovarian cancer	0.000297	0.00054	CcSEcCtD
Niacin—Arthralgia—Epirubicin—ovarian cancer	0.000297	0.00054	CcSEcCtD
Niacin—Nausea—Paclitaxel—ovarian cancer	0.000296	0.000538	CcSEcCtD
Niacin—SLC16A1—Hemostasis—SPARC—ovarian cancer	0.000295	0.00168	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000295	0.000537	CcSEcCtD
Niacin—QPRT—Disease—IL6ST—ovarian cancer	0.000294	0.00167	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CG—ovarian cancer	0.000292	0.00166	CbGpPWpGaD
Niacin—Dry mouth—Epirubicin—ovarian cancer	0.000291	0.000528	CcSEcCtD
Niacin—SLC16A3—Hemostasis—CAV1—ovarian cancer	0.00029	0.00165	CbGpPWpGaD
Niacin—Vertigo—Doxorubicin—ovarian cancer	0.00029	0.000528	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00029	0.00165	CbGpPWpGaD
Niacin—Syncope—Doxorubicin—ovarian cancer	0.00029	0.000527	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—ovarian cancer	0.000289	0.000526	CcSEcCtD
Niacin—Diarrhoea—Docetaxel—ovarian cancer	0.000289	0.000525	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—IL6ST—ovarian cancer	0.000288	0.00164	CbGpPWpGaD
Niacin—Palpitations—Doxorubicin—ovarian cancer	0.000285	0.000519	CcSEcCtD
Niacin—Oedema—Epirubicin—ovarian cancer	0.000285	0.000518	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000285	0.000518	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000284	0.000516	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000283	0.00161	CbGpPWpGaD
Niacin—QPRT—Disease—APC—ovarian cancer	0.000282	0.0016	CbGpPWpGaD
Niacin—Cough—Doxorubicin—ovarian cancer	0.000282	0.000512	CcSEcCtD
Niacin—Shock—Epirubicin—ovarian cancer	0.00028	0.00051	CcSEcCtD
Niacin—Dizziness—Docetaxel—ovarian cancer	0.000279	0.000508	CcSEcCtD
Niacin—Tachycardia—Epirubicin—ovarian cancer	0.000278	0.000506	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PIK3CG—ovarian cancer	0.000277	0.00158	CbGpPWpGaD
Niacin—Skin disorder—Epirubicin—ovarian cancer	0.000277	0.000503	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000275	0.000501	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—ovarian cancer	0.000275	0.0005	CcSEcCtD
Niacin—Myalgia—Doxorubicin—ovarian cancer	0.000275	0.0005	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000273	0.000497	CcSEcCtD
Niacin—Anorexia—Epirubicin—ovarian cancer	0.000272	0.000494	CcSEcCtD
Niacin—Dry mouth—Doxorubicin—ovarian cancer	0.000269	0.000489	CcSEcCtD
Niacin—Vomiting—Docetaxel—ovarian cancer	0.000269	0.000488	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000268	0.00153	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—ovarian cancer	0.000268	0.00152	CbGpPWpGaD
Niacin—Rash—Docetaxel—ovarian cancer	0.000266	0.000484	CcSEcCtD
Niacin—Hypotension—Epirubicin—ovarian cancer	0.000266	0.000484	CcSEcCtD
Niacin—Dermatitis—Docetaxel—ovarian cancer	0.000266	0.000484	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PIK3CG—ovarian cancer	0.000265	0.0015	CbGpPWpGaD
Niacin—Headache—Docetaxel—ovarian cancer	0.000265	0.000481	CcSEcCtD
Niacin—Oedema—Doxorubicin—ovarian cancer	0.000264	0.000479	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000264	0.000479	CcSEcCtD
Niacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00026	0.000472	CcSEcCtD
Niacin—QPRT—Metabolism—CAV1—ovarian cancer	0.000259	0.00147	CbGpPWpGaD
Niacin—Shock—Doxorubicin—ovarian cancer	0.000259	0.000472	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PPP2R1A—ovarian cancer	0.000258	0.00147	CbGpPWpGaD
Niacin—Insomnia—Epirubicin—ovarian cancer	0.000258	0.000469	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—ovarian cancer	0.000257	0.000468	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—PIK3CD—ovarian cancer	0.000257	0.00146	CbGpPWpGaD
Niacin—Skin disorder—Doxorubicin—ovarian cancer	0.000256	0.000466	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—ovarian cancer	0.000256	0.000465	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000255	0.000463	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—ovarian cancer	0.000254	0.000462	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000253	0.00144	CbGpPWpGaD
Niacin—Somnolence—Epirubicin—ovarian cancer	0.000253	0.000461	CcSEcCtD
Niacin—Anorexia—Doxorubicin—ovarian cancer	0.000251	0.000457	CcSEcCtD
Niacin—Nausea—Docetaxel—ovarian cancer	0.000251	0.000456	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—ovarian cancer	0.000251	0.000456	CcSEcCtD
Niacin—QPRT—Disease—PIK3CD—ovarian cancer	0.000248	0.00141	CbGpPWpGaD
Niacin—Decreased appetite—Epirubicin—ovarian cancer	0.000248	0.00045	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000247	0.0014	CbGpPWpGaD
Niacin—Hypotension—Doxorubicin—ovarian cancer	0.000246	0.000448	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—ovarian cancer	0.000246	0.0014	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000246	0.000447	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000245	0.00139	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PPP2R1A—ovarian cancer	0.000245	0.00139	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CD—ovarian cancer	0.000244	0.00138	CbGpPWpGaD
Niacin—Pain—Epirubicin—ovarian cancer	0.000244	0.000443	CcSEcCtD
Niacin—SLC16A3—Metabolism—YAP1—ovarian cancer	0.000243	0.00138	CbGpPWpGaD
Niacin—NNMT—Metabolism—CAV1—ovarian cancer	0.000241	0.00137	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00024	0.000437	CcSEcCtD
Niacin—Insomnia—Doxorubicin—ovarian cancer	0.000238	0.000434	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—ovarian cancer	0.000237	0.00135	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—ovarian cancer	0.000237	0.00043	CcSEcCtD
Niacin—QPRT—Metabolism—PIK3CG—ovarian cancer	0.000236	0.00134	CbGpPWpGaD
Niacin—Dyspnoea—Doxorubicin—ovarian cancer	0.000235	0.000427	CcSEcCtD
Niacin—Somnolence—Doxorubicin—ovarian cancer	0.000234	0.000426	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000234	0.00133	CbGpPWpGaD
Niacin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000233	0.000424	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PIK3CD—ovarian cancer	0.000233	0.00132	CbGpPWpGaD
Niacin—Dyspepsia—Doxorubicin—ovarian cancer	0.000232	0.000422	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—ovarian cancer	0.000229	0.000417	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—ovarian cancer	0.000228	0.00129	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000228	0.000414	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—IL2—ovarian cancer	0.000227	0.00129	CbGpPWpGaD
Niacin—Urticaria—Epirubicin—ovarian cancer	0.000226	0.000412	CcSEcCtD
Niacin—Pain—Doxorubicin—ovarian cancer	0.000225	0.00041	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—ovarian cancer	0.000225	0.000409	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—ovarian cancer	0.000225	0.000409	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000225	0.00128	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—ovarian cancer	0.000225	0.00128	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYTB—ovarian cancer	0.000224	0.00127	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CB—ovarian cancer	0.000224	0.00127	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CG—ovarian cancer	0.00022	0.00125	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB2—ovarian cancer	0.000219	0.00125	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000217	0.00124	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CB—ovarian cancer	0.000216	0.00123	CbGpPWpGaD
Niacin—QPRT—Disease—MTOR—ovarian cancer	0.000216	0.00123	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000216	0.000392	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CXCL8—ovarian cancer	0.000215	0.00122	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2—ovarian cancer	0.000215	0.00122	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SOD1—ovarian cancer	0.000215	0.00122	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PPP2R1A—ovarian cancer	0.000213	0.00121	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CB—ovarian cancer	0.000212	0.00121	CbGpPWpGaD
Niacin—Hypersensitivity—Epirubicin—ovarian cancer	0.00021	0.000382	CcSEcCtD
Niacin—Urticaria—Doxorubicin—ovarian cancer	0.000209	0.000381	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—ovarian cancer	0.000208	0.000379	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—ovarian cancer	0.000208	0.000379	CcSEcCtD
Niacin—QPRT—Metabolism—PIK3CD—ovarian cancer	0.000208	0.00118	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL2—ovarian cancer	0.000206	0.00117	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TERT—ovarian cancer	0.000205	0.00117	CbGpPWpGaD
Niacin—Asthenia—Epirubicin—ovarian cancer	0.000204	0.000372	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CXCL8—ovarian cancer	0.000204	0.00116	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1B—ovarian cancer	0.000203	0.00115	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CB—ovarian cancer	0.000203	0.00115	CbGpPWpGaD
Niacin—Pruritus—Epirubicin—ovarian cancer	0.000202	0.000366	CcSEcCtD
Niacin—SLC16A3—Metabolism—FASN—ovarian cancer	0.000198	0.00113	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BRIP1—ovarian cancer	0.000196	0.00111	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPP1CC—ovarian cancer	0.000196	0.00111	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SLC5A5—ovarian cancer	0.000195	0.00111	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2—ovarian cancer	0.000195	0.00111	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—ovarian cancer	0.000195	0.000354	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—TERT—ovarian cancer	0.000194	0.0011	CbGpPWpGaD
Niacin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000194	0.000353	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000193	0.0011	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000193	0.0011	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CD—ovarian cancer	0.000193	0.0011	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—ovarian cancer	0.000192	0.00109	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CAV1—ovarian cancer	0.00019	0.00108	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—ovarian cancer	0.000189	0.000344	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC2A1—ovarian cancer	0.000188	0.00107	CbGpPWpGaD
Niacin—Dizziness—Epirubicin—ovarian cancer	0.000188	0.000343	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000187	0.00106	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—ovarian cancer	0.000187	0.00106	CbGpPWpGaD
Niacin—Pruritus—Doxorubicin—ovarian cancer	0.000186	0.000339	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IL2—ovarian cancer	0.000186	0.00106	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ESR1—ovarian cancer	0.000183	0.00104	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—ovarian cancer	0.000181	0.000329	CcSEcCtD
Niacin—QPRT—Metabolism—PIK3CB—ovarian cancer	0.000181	0.00103	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1B1—ovarian cancer	0.000181	0.00103	CbGpPWpGaD
Niacin—Diarrhoea—Doxorubicin—ovarian cancer	0.00018	0.000328	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—IL6ST—ovarian cancer	0.00018	0.00102	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CAV1—ovarian cancer	0.00018	0.00102	CbGpPWpGaD
Niacin—Rash—Epirubicin—ovarian cancer	0.00018	0.000327	CcSEcCtD
Niacin—Dermatitis—Epirubicin—ovarian cancer	0.000179	0.000326	CcSEcCtD
Niacin—Headache—Epirubicin—ovarian cancer	0.000178	0.000325	CcSEcCtD
Niacin—Dizziness—Doxorubicin—ovarian cancer	0.000174	0.000317	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—ESR1—ovarian cancer	0.000173	0.000985	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—ovarian cancer	0.000173	0.000982	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—ovarian cancer	0.000173	0.000982	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NRAS—ovarian cancer	0.000173	0.000982	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000172	0.000975	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6ST—ovarian cancer	0.00017	0.000969	CbGpPWpGaD
Niacin—Nausea—Epirubicin—ovarian cancer	0.000169	0.000308	CcSEcCtD
Niacin—NNMT—Metabolism—PIK3CB—ovarian cancer	0.000168	0.000957	CbGpPWpGaD
Niacin—Vomiting—Doxorubicin—ovarian cancer	0.000168	0.000305	CcSEcCtD
Niacin—QPRT—Disease—STAT3—ovarian cancer	0.000167	0.00095	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—ovarian cancer	0.000167	0.000947	CbGpPWpGaD
Niacin—Rash—Doxorubicin—ovarian cancer	0.000166	0.000302	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—ovarian cancer	0.000166	0.000302	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—MAPK3—ovarian cancer	0.000165	0.00094	CbGpPWpGaD
Niacin—Headache—Doxorubicin—ovarian cancer	0.000165	0.0003	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PIK3CG—ovarian cancer	0.000164	0.000931	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—ovarian cancer	0.000164	0.000931	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—ovarian cancer	0.000164	0.000931	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPP2R1A—ovarian cancer	0.00016	0.000911	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK3—ovarian cancer	0.00016	0.000907	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	0.000159	0.000904	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—ovarian cancer	0.000158	0.0009	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MAPK1—ovarian cancer	0.000157	0.000895	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—ovarian cancer	0.000157	0.000894	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CAV1—ovarian cancer	0.000157	0.000892	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK3—ovarian cancer	0.000157	0.000891	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000157	0.000891	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—ovarian cancer	0.000157	0.000285	CcSEcCtD
Niacin—QPRT—Metabolism—PTEN—ovarian cancer	0.000156	0.000889	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—ovarian cancer	0.000156	0.000889	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—ovarian cancer	0.000155	0.000883	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK1—ovarian cancer	0.000152	0.000863	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—ovarian cancer	0.000152	0.000863	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CD—ovarian cancer	0.000152	0.000863	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—ovarian cancer	0.00015	0.000855	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK3—ovarian cancer	0.00015	0.000851	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK1—ovarian cancer	0.000149	0.000848	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—ovarian cancer	0.000149	0.000848	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—ovarian cancer	0.000149	0.000846	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—ovarian cancer	0.000149	0.000845	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000148	0.000839	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMS—ovarian cancer	0.000146	0.000831	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—ovarian cancer	0.000145	0.000827	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CD—ovarian cancer	0.000144	0.000818	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—ovarian cancer	0.000143	0.000815	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—ovarian cancer	0.000143	0.000812	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000143	0.00081	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK1—ovarian cancer	0.000142	0.00081	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—ovarian cancer	0.000141	0.000801	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—ovarian cancer	0.000137	0.000776	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—ovarian cancer	0.000135	0.000765	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—ovarian cancer	0.000134	0.000762	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—ovarian cancer	0.000132	0.000752	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—ovarian cancer	0.000132	0.000752	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—ovarian cancer	0.000132	0.000749	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—YAP1—ovarian cancer	0.000131	0.000747	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—ovarian cancer	0.000129	0.000736	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—ovarian cancer	0.000127	0.000723	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—ovarian cancer	0.000127	0.000723	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—ovarian cancer	0.000126	0.000718	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—ovarian cancer	0.000126	0.000714	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—ovarian cancer	0.000125	0.000713	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTOR—ovarian cancer	0.000125	0.000713	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—ovarian cancer	0.000124	0.000706	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—ovarian cancer	0.000124	0.000703	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—ovarian cancer	0.000123	0.000698	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—ovarian cancer	0.000122	0.000693	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—ovarian cancer	0.000122	0.000692	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—ovarian cancer	0.000122	0.000691	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—ovarian cancer	0.000121	0.000687	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—ovarian cancer	0.000121	0.000685	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—ovarian cancer	0.00012	0.000681	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—ovarian cancer	0.00012	0.00068	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—ovarian cancer	0.000118	0.000673	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAV1—ovarian cancer	0.000118	0.000669	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—ovarian cancer	0.000118	0.000669	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—ovarian cancer	0.000117	0.000667	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—ovarian cancer	0.000117	0.000663	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—ovarian cancer	0.000116	0.000662	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—ovarian cancer	0.000115	0.000656	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—ovarian cancer	0.000115	0.000655	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—ovarian cancer	0.000115	0.000654	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—ovarian cancer	0.000115	0.000652	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—ovarian cancer	0.000114	0.00065	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—ovarian cancer	0.000114	0.00065	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—ovarian cancer	0.000112	0.000638	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—ovarian cancer	0.000112	0.000634	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—ovarian cancer	0.000111	0.000632	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—ovarian cancer	0.00011	0.000627	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—ovarian cancer	0.000109	0.000622	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—ovarian cancer	0.000109	0.00062	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—ovarian cancer	0.000108	0.000616	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—ovarian cancer	0.000108	0.000612	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—ovarian cancer	0.000107	0.00061	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FASN—ovarian cancer	0.000107	0.000609	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—ovarian cancer	0.000106	0.000601	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—ovarian cancer	0.000105	0.000599	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—ovarian cancer	0.000103	0.000587	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—ovarian cancer	0.000103	0.000583	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—ovarian cancer	0.000102	0.000581	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—ovarian cancer	0.000102	0.00058	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A1—ovarian cancer	0.000102	0.000579	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—ovarian cancer	0.000101	0.000574	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—ovarian cancer	0.000101	0.000572	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—ovarian cancer	9.79e-05	0.000557	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—ovarian cancer	9.77e-05	0.000555	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1B1—ovarian cancer	9.76e-05	0.000555	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—ovarian cancer	9.69e-05	0.000551	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NME2—ovarian cancer	9.69e-05	0.000551	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—ovarian cancer	9.67e-05	0.00055	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—ovarian cancer	9.5e-05	0.00054	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—ovarian cancer	9.43e-05	0.000536	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK1—ovarian cancer	9.3e-05	0.000528	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—ovarian cancer	9.29e-05	0.000528	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK3—ovarian cancer	9.26e-05	0.000527	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—ovarian cancer	9.02e-05	0.000513	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—ovarian cancer	9.01e-05	0.000512	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK1—ovarian cancer	8.81e-05	0.000501	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—ovarian cancer	8.81e-05	0.000501	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—ovarian cancer	8.78e-05	0.000499	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPP2R1A—ovarian cancer	8.65e-05	0.000492	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—ovarian cancer	8.54e-05	0.000486	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—ovarian cancer	8.44e-05	0.00048	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—ovarian cancer	8.38e-05	0.000476	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—ovarian cancer	8.32e-05	0.000473	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—ovarian cancer	8.22e-05	0.000467	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—ovarian cancer	8.08e-05	0.00046	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—ovarian cancer	8.07e-05	0.000459	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—ovarian cancer	8.04e-05	0.000457	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—ovarian cancer	7.89e-05	0.000449	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—ovarian cancer	7.8e-05	0.000444	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK1—ovarian cancer	7.69e-05	0.000437	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—ovarian cancer	7.65e-05	0.000435	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—ovarian cancer	7.46e-05	0.000424	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—ovarian cancer	7.4e-05	0.000421	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—ovarian cancer	7.26e-05	0.000413	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—ovarian cancer	7.14e-05	0.000406	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—ovarian cancer	7.1e-05	0.000404	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—ovarian cancer	7.08e-05	0.000402	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—ovarian cancer	6.77e-05	0.000385	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—ovarian cancer	6.67e-05	0.000379	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—ovarian cancer	6.59e-05	0.000375	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—ovarian cancer	6.46e-05	0.000367	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAV1—ovarian cancer	6.36e-05	0.000362	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—ovarian cancer	6.25e-05	0.000355	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYTB—ovarian cancer	6.25e-05	0.000355	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—ovarian cancer	6.17e-05	0.000351	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—ovarian cancer	5.79e-05	0.000329	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPP1CC—ovarian cancer	5.46e-05	0.00031	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BRIP1—ovarian cancer	5.46e-05	0.00031	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—ovarian cancer	5.45e-05	0.00031	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—ovarian cancer	5.09e-05	0.000289	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—ovarian cancer	5.01e-05	0.000285	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—ovarian cancer	4.44e-05	0.000252	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—ovarian cancer	4.09e-05	0.000233	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—ovarian cancer	3.84e-05	0.000218	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—YAP1—ovarian cancer	3.66e-05	0.000208	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FASN—ovarian cancer	2.98e-05	0.00017	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.94e-05	0.000167	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.84e-05	0.000161	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.72e-05	0.000155	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—ovarian cancer	2.71e-05	0.000154	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.41e-05	0.000137	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—ovarian cancer	2.24e-05	0.000127	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—ovarian cancer	2.21e-05	0.000126	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—ovarian cancer	2.2e-05	0.000125	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAV1—ovarian cancer	1.77e-05	0.000101	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.61e-05	9.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.42e-05	8.06e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.24e-05	7.03e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—ovarian cancer	1.07e-05	6.07e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—ovarian cancer	7.54e-06	4.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—ovarian cancer	6.16e-06	3.5e-05	CbGpPWpGaD
